COVID-19 vaccines about to be produced in Taizhou!Time of issue : 2020-11-26
On the morning of November 23, the news of the official kick-off of the COVID-19 vaccine industrialization base of Jiangsu Rec-Biotechnology Co., Ltd caught the eyes of the public.
News | RecBio completed series B round financingTime of issue : 2020-11-11
Following the completion of CNY 500 million series A round financing in early 2019, Jiangsu Rec-Biotechnology Co., Ltd (hereinafter referred to as RecBio) recently completed its series B round financing with an amount of over USD 100 million.
A Noah's Ark to combat COVID-19Time of issue : 2020-10-27
The diagnostic reagents section of China Medical City has collectively risen to prominence in the fight against the COVID-19 pandemic, and made outstanding contributions.
Further promote the implementation of IPD system to lay the foundation for a better future of RecBio - Written on the launch of the IPD Phase IITime of issue : 2020-10-27
Our company's ongoing development of the Integrated Product Development (IPD) system is a foundation for RecBio's great cause. IPD is an advanced, scientific and mature system of product development models, concepts and methods.
The construction of RecBio industrialization base was started on May 18, 2020Time of issue : 2020-10-27
As the zone with the highest concentration of vaccine enterprises in China, China Medical City has taken one step closer to the goal of being the "national landmark of the vaccine industry".
Congratulations on the launch of the first IPMT meetingTime of issue : 2020-10-27
The meeting was chaired by Li Bu, GM Assistant and HR Director; GM Liu Yong made the kick-off speech.